MannKind Corporation (NASDAQ:MNKD) Q1 2025 Earnings Call Transcript
Operator: Good morning, and welcome to the MannKind Corporation First Quarter 2025 Financial Results Earnings Call.
Mannkind Corp (MNKD)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | VenBio Select Advisor Kurt Von Emster | 8,750,000 | $44,012,500 | 0.69% | |
| 2. | Nitorum Capital Seth Rosen | 7,785,702 | $39,162,081 | -11% | 5.5% |
| 3. | Millennium Management Israel Englander | 5,822,590 | $29,287,628 | +69% | 0.02% |
| 4. | D E Shaw D. E. Shaw | 3,837,634 | $19,303,299 | -11% | 0.02% |
| 5. | Two Sigma Advisors John Overdeck And David Siegel | 3,735,627 | $18,790,204 | +21% | 0.04% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.93 | 791 | Officer | 728,997 | 2022-07-31 | Filing | |
| $2.93 | 3,147 | Officer, Director | 2,084,486 | 2022-07-31 | Filing | |
| $2.93 | 4,581 | Officer | 830,650 | 2022-07-31 | Filing | |
| $2.93 | 5,000 | Officer | 781,690 | 2022-07-31 | Filing | |
| $2.71 | 36,900 | Officer | 576,690 | 2022-02-28 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.00 | 64,085 | 925,258 | 2025-06-10 | Filing | ||
| $4.40 | 12,078 | 989,343 | 2025-05-20 | Filing | ||
| $4.41 | 2,345 | 879,546 | 2025-05-20 | Filing | ||
| $4.68 | 32,179 | 772,427 | 2025-05-13 | Filing | ||
| $4.69 | 80,144 | 1,006,611 | 2025-05-13 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 24,486,939 | $123,169,302 | 0% | |
| 2. | 17,322,179 | $87,130,560 | 0% | |
| 3. | 9,469,977 | $47,633,984 | 0% | |
| 4. | 6,786,105 | $34,141,692 | 0% | |
| 5. | 6,560,268 | $32,998,148 | 0.01% |
News See All
10 Best Cancer Stocks to Invest in for Long-Term Gains
After cardiovascular disease, cancer is the second most common cause of mortality worldwide.
11 Best Quality Penny Stocks to Buy According to Hedge Funds
The quality factor in stocks refers to companies with strong fundamentals, financial stability, and reliable performance, with an aim for resilience rather than speculative growth.
13 Best Biotech Penny Stocks to Buy According to Hedge Funds
Peter Marks's departure from the FDA has left innovators concerned regarding the current state of the review program at the FDA. Marks had impacts on two key areas.
MannKind Corporation (NASDAQ:MNKD) Q4 2024 Earnings Call Transcript
Operator: Good afternoon and welcome to the MannKind Corporation Fourth Quarter and Year End 2024 Financial Results Earnings Call.
10 Best Diabetes Stocks To Buy Under $10
About 422 million people worldwide have diabetes, according to the WHO, and most of them live in low- or middle-income nations. Every year, diabetes directly causes 1.5 million deaths on average.
MannKind Corporation (NASDAQ:MNKD) Q3 2024 Earnings Call Transcript
Operator: Good afternoon, and welcome to the MannKind Corporation Third Quarter 2024 Financial Results Earnings Call.
14 Worst 52-Week High Stocks to Buy According to Short Sellers
The start of the US Federal Reserve cutting cycle ushers a new era in the investment world after one of the longest bull runs.
MannKind Corporation (NASDAQ:MNKD) Q2 2024 Earnings Call Transcript
Operator: Good morning and welcome to the MannKind Corporation Second Quarter 2024 Financial Results Earnings Call.
MannKind Corporation (NASDAQ:MNKD) Q1 2024 Earnings Call Transcript
Operator: Good afternoon, and welcome to the MannKind Corporation 2024 First Quarter Financial Results Earnings Call.
Billionaire Hedge Funds
